Cite
HARVARD Citation
Delany-Moretlwe, S. et al. (2022). Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Lancet. 399 (10337), pp. 1779-1789. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Delany-Moretlwe, S. et al. (2022). Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Lancet. 399 (10337), pp. 1779-1789. [Online].